This inventor holds 35 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Controlled Release Formulations. Top assignees: Purdue Pharma L.p., Euro-Celtique S.a.. Active years: 2004-2019.
Location History:
- Congres, NY (US) (2018)
- Congers, NY (US) (2004 - 2019)
Company Filing History:
Years Active: 2004-2019
Areas of Expertise:
Title: Alfred P. Tonelli: A Pioneer in Controlled-Release Medications
Introduction:
Alfred P. Tonelli, based in Congers, NY, is a renowned inventor and researcher in the field of controlled-release medications. With an impressive portfolio of 35 patents, Tonelli has been at the forefront of developing innovative solutions for enhancing drug delivery mechanisms for improved patient outcomes. This article explores his latest patents, career highlights, collaborations, and highlights his contribution to the pharmaceutical industry.
Latest Patents:
Tonelli's recent patents showcase his expertise in developing controlled-release medications. One of his notable inventions is the "Controlled Release Hydrocodone Formulations." This invention introduces a solid oral dosage form that provides an analgesically effective amount of hydrocodone over a 12-hour period. The dosage form incorporates a controlled-release material, making it suitable for twice-a-day administration. This breakthrough ensures improved pain management for patients and convenience in medication administration.
Methods of Manufacturing Oral Dosage Forms:
Another noteworthy patent is Tonelli's methodology for manufacturing oral dosage forms. This invention is in line with his controlled-release research and presents a solid oral dosage form containing hydrocodone or its pharmaceutical salt. By combining an efficacious amount of hydrocodone with a controlled-release material, Tonelli's invention enables the creation of oral dosage forms suitable for twice-daily administration. This streamlined approach has undoubtedly advanced the field of drug delivery.
Career Highlights:
Tonelli's extensive career has been marked by numerous accomplishments within the pharmaceutical industry. He has made significant contributions during his time at prestigious companies such as Purdue Pharma L.P. and Euro-Celtique S.A. Tonelli's focus on controlled-release medications has allowed for the development of groundbreaking products that improve treatment effectiveness and patient adherence. His dedication to advancing pharmaceutical technology has earned him recognition as a leader in the field.
Collaborations:
Throughout his career, Tonelli has worked alongside esteemed professionals who share his passion for innovation. Benjamin Oshlack and John K. Masselink are notable collaborators, with their combined expertise complementing Tonelli's own contributions. Collaborations like these are essential in pushing the boundaries of scientific discovery and laying the foundation for future breakthroughs.
Conclusion:
Alfred P. Tonelli's remarkable career and numerous patents reflect his dedication to advancing the field of controlled-release medications. Through his innovations, such as the controlled release hydrocodone formulations and his manufacturing methodologies, Tonelli has revolutionized drug delivery, improving patient outcomes and enhancing convenience in medication administration. Tonelli's collaborations with esteemed colleagues have further fueled his success, making him an invaluable contributor to the pharmaceutical industry. As we eagerly anticipate his future inventions, Tonelli's significant contributions serve as an inspiration to aspiring inventors and researchers in the field of controlled-release medications.